Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NextCure, Inc.

NASDAQ: NXTC · Life Sciences · 7 alerts · CIK 1661059

Share price
$6.68Close, Nov 16
Market cap
$30.6M
Shares outstanding
4.58MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NextCure, Inc. filings on SEC EDGAR ↗

4:11 PM ET 8-K
Court & Legal Update

NextCure Court & Legal Update

NextCure filed a petition under Section 205 of the Delaware General Corporation Law seeking to validate a 1-for-12 reverse stock split previously implemented in July 2025. The company is seeking court validation due to uncertainty regarding the voting standard used for the split's approval in light of recent DGCL amendments and its pending merger with Avere Therapeutics. A court hearing on the validation petition is scheduled for November 6, 2026.

Counterparty
Delaware Court of Chancery

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.